LeMaitre Vascular Sees Q3 EPS $0.42-$0.46 Vs $0.42 Est.; Revenue $52.7M-$54.7M Vs $52.35M Est.; FY24 EPS $1.82-$1.91 Vs $1.77 Est.; Revenue $216.8M-$220.8M Vs $215.05M Est.
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular has provided its Q3 and FY24 guidance, projecting higher-than-expected EPS and revenue. For Q3, EPS is expected to be $0.42-$0.46, and revenue is projected at $52.7M-$54.7M. For FY24, EPS is expected to be $1.82-$1.91, and revenue is projected at $216.8M-$220.8M.
August 01, 2024 | 9:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular has provided optimistic Q3 and FY24 guidance, with EPS and revenue projections exceeding estimates. This positive outlook is likely to boost investor confidence and drive the stock price up in the short term.
The company's guidance for both Q3 and FY24 shows higher-than-expected EPS and revenue, which is a strong positive signal for investors. This is likely to result in a short-term increase in the stock price as the market reacts to the optimistic projections.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100